Drish Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 01-07-2024
- Paid Up Capital ₹ 0.50 M
as on 01-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.65 Cr
as on 01-07-2024
- Revenue %
(FY 2020)
- Ebitda
- Net Worth
- Total Assets %
(FY 2020)
About Drish Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.65 Cr.
Qudrat Paul, Poonam Paul, and Indereshwar Paul serve as directors at the Company.
- CIN/LLPIN
U24100PB2010PLC034373
- Company No.
034373
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Drish Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Qudrat Paul  | Director | 03-Jul-2021 | Current |
| Poonam Paul | Director | 20-Oct-2010 | Current |
| Indereshwar Paul | Director | 20-Oct-2010 | Current |
Financial Performance and Corporate Structure Insights of Drish Lifesciences.
Drish Lifesciences Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Drish Lifesciences?
In 2020, Drish Lifesciences had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rehmat International Private LimitedActive 11 years 10 daysQudrat Paul and Indereshwar Paul are mutual person
- G K Leather Company Private LimitedActive 34 years 6 months
Poonam Paul and Indereshwar Paul are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 27 Apr 2012 | ₹1.65 Cr | Open |
How Many Employees Work at Drish Lifesciences?
Drish Lifesciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drish Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drish Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
